Questcor Pharmaceuticals

Looking for another reason to dislike drug companies? Good news: Some companies systematically use charitable giving as a way to raise their drug prices with minimal public awareness. Bloomberg’s Benjamin Elgin and Robert Langreth reported on a number of cases in which drug companies seem...

Analysts believe that Medtronic (NYSE: MDT), Teva Pharmaceuticals (NYSE: TEVA), UnitedHealth Group (NYSE: UNH) and Zimmer Holdings (NYSE: ZMH) shares still have some headroom, though they all have handily outperformed the S&P 500 over the past six months. They are all dividend payers as well....

While Amgen (NASDAQ: AMGN) saw a sizable dip in short interest between the April 30 and May 15 settlement dates, short sellers piled on Medivation (NASDAQ: MDVN) and Pharmacyclics (NASDAQ: PCYC). Among other leading biotechs and emerging pharmaceuticals, gains in the number of their shares sold...

Biotech stocks have proved to be volatile this year, and short sellers piled on Incyte (NASDAQ: INCY) between the April 15 and April 30 settlement dates. Pharmacyclics (NASDAQ: PCYC) and Regeneron Pharmaceuticals (NASDAQ: REGN) also saw double-digit percentage increases in the number of their...

In a period when many biotech stocks were slipping, short sellers moved on many of the leading biotech and emerging pharmaceuticals between the March 14 and March 31 settlement dates. But Amgen (NASDAQ: AMGN), Celgene (NASDAQ: CELG) and Dendreon (NASDAQ: DNDN) were among those that bucked the...

U.S. stocks declined for the third straight day in another trading session in which Internet, social media, biotechnology and momentum stocks sold off. The Dow suffered another triple-digit point loss while the three major indices each saw declines greater than one percent. The timing of the...

After largely shying away in the previous period, short sellers found renewed interest in many of the leading biotech and emerging pharmaceutical companies between the February 28 and March 14 settlement dates. But Celgene (NASDAQ: CELG), Medivation (NASDAQ: MDVN) and Pharmacyclics (NASDAQ: PCYC...

Short interest in most of the leading biotech and emerging pharmaceutical companies declined between the February 14 and February 28 settlement dates. But Biogen Idec (NASDAQ: BIIB), BioMarin Pharmaceutical (NASDAQ: BMRN) and Medivation (NASDAQ: MDVN) bucked that trend. Short interest in Gilead...

Among the leading biotech and emerging pharmaceutical companies, Amgen (NASDAQ: AMGN), Biogen Idec (NASDAQ: BIIB) and BioMarin Pharmaceutical (NASDAQ: BMRN) saw the largest percentage increases in short interest between the January 31 and February 15 settlement dates. Alexion Pharmaceuticals,...

Major indices finished Wednesday's trading session relatively flat as the Fed's minutes released had no impact on the markets. Minutes released from the Federal Reserve's latest meeting re-affirmed that many members on the committee wanted to proceed with caution in trimming the $85 billion...

Major indices barely budged Thursday following yesterday's monster rally after the Fed announced it will begin tapering. Overall volume was below average which is typical in the final trading days of the year. Next week will be shortened as investors break for Christmas and a week later for new...

This weekend in Barron's online: the fall Big Money poll results, as well as the prospects for AT&T, Outerwall, Questcor Pharmaceuticals and more. Cover Story "Raking In Returns" by Jack Willoughby. American money managers expect stocks to rise seven percent between now and the middle of...

Oppenheimer has a new team of analysts focused on biotechnology and specialty pharmaceuticals. And, research from the new team includes recommendations to buy shares of Antares Pharma (NASDAQ: ATRS), Intercept Pharmaceuticals (NASDAQ: ICPT), Questcor Pharmaceuticals (NASDAQ: QCOR) and ViroPharma...

It is not unusual for stocks on a tear to overrun their mean price targets, which is a signal of how far analysts on average expect the share price to climb. Some of the top-performing health care stocks over the past six months that pay dividends, such as Becton, Dickinson (NYSE: BDX), Bristol-...

Some smaller health care companies saw unusual movement in their stocks on Friday. And not just in Anacor Pharmaceuticals (NASDAQ: ANAC), Halozyme Therapeutics (NASDAQ: HALO), Puma Biotechnology (NYSE: PBYI) and Questcor Pharmaceuticals (NASDAQ: QCOR), which are discussed below. But also ACADIA...